Search

Your search keyword '"Hellmis E"' showing total 6 results
Start Over Author "Hellmis E" Journal annals of oncology
6 results on '"Hellmis E"'

1. 679P Final results on efficacy and patient reported outcomes (PRO) of a randomized phase II trial investigating nivolumab switch-maintenance after TKI induction in metastatic clear cell renal cell carcinoma (mRCC) patients (NIVOSWITCH)

Author

Darr, C., primary, Zschäbitz, S., additional, Ivanyi, P., additional, Wirth, M., additional, Staib, P., additional, Schostak, M., additional, Müller, L., additional, Metz, M., additional, Bergmann, L., additional, Steiner, T., additional, Lorch, A., additional, Schütt, P., additional, Rafiyan, M-R., additional, Hellmis, E., additional, Hinke, A., additional, Mänz, M., additional, Meiler, J., additional, Kretz, T., additional, Flörcken, A., additional, and Grünwald, V., additional

Published
2021
Full Text
View/download PDF

2. 1890P Switch-maintenance therapy with nivolumab in TKI-sensitive patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis for PD-L1 status of a randomized phase II study (NIVOSWITCH)

Author

Darr, C., Ivanyi, P., Wirth, M., Zschäbitz, S., Schostak, M., Mueller, L., Steiner, T., Welslau, M.K., Schuett, P., Lorch, A., Rafiyan, M-R., Hellmis, E., Meiler, J., Kretz, T., Loidl, W.C., Floercken, A., Stöhr, C.G., Eckstein, M., Hartmann, A., and Grünwald, V.

Published
2023
Full Text
View/download PDF

3. A phase II trial of TKI induction followed by a randomized comparison between nivolumab or TKI continuation in renal cell carcinoma (NIVOSWITCH)

Author

Grünwald, V., primary, Grüllich, C., additional, Ivanyi, P., additional, Wirth, M., additional, Staib, P., additional, Schostak, M., additional, Dargatz, P., additional, Müller, L., additional, Metz, M., additional, Bergmann, L., additional, Welslau, M.K., additional, Schütt, P., additional, Rafiyan, M.-R., additional, Hellmis, E., additional, Hinke, A., additional, Meiler, J., additional, Kretz, T., additional, Loidl, W.C., additional, Flörcken, A., additional, and Steiner, T., additional

Published
2019
Full Text
View/download PDF

4. Abiraterone acetate plus prednisone and LHRH therapy versus abiraterone acetate plus prednisone while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer: Results from the SPARE-trial (NCT02077634)

Author

Ohlmann, C., primary, Roger, Z., additional, Rüssel, C., additional, Hellmis, E., additional, Suttmann, H., additional, Janssen, M., additional, Hübner, A., additional, Dahm, J., additional, Gleißner, J., additional, Scheffler, M., additional, Feyerabend, S., additional, Telle, J., additional, and Klier, J., additional

Published
2018
Full Text
View/download PDF

6. 810P - Abiraterone acetate plus prednisone and LHRH therapy versus abiraterone acetate plus prednisone while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer: Results from the SPARE-trial (NCT02077634)

Author

Ohlmann, C., Roger, Z., Rüssel, C., Hellmis, E., Suttmann, H., Janssen, M., Hübner, A., Dahm, J., Gleißner, J., Scheffler, M., Feyerabend, S., Telle, J., and Klier, J.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results